drugset / Trial / NCT03265171
A Single-patient Study of Repeat-dose Administration of Prometic Plasminogen (Human) Intravenous
Summary
These are single-patient studies with repeat-dose administration of ProMetic Plasminogen IV infusion in one adult and one child with hypoplasminogenemia. These patients are under treatment to address wound healing and obstructions.
Timeline
- Start
- —
- Primary completion
- —
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Plasminogen (Human) | Protein / enzyme biologic | — | Intravenous |